1. Eight healthy male volunteers (aged 22-39 years) supplemented their normal daily diet with 15 g encapsulated fish oil (MaxEPA) for a 6 week period. Fasting blood samples were taken before, at the completion of and 3 months after the period of supplementation.
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M . . I . GIBNEY AND CAROLINE BOLTON-SMITH phospholipase (EC 3 . 1 . 4 . 1). Thus, fish-oil feeding could exert an effect on platelet function independent of its effect on platelet thromboxane A, synthesis. In the present study, variation in polarization values of the fluorescent probe 1,6-diphenyl-1,3,5hexatriene (DPH) were used as an inverse indicator of platelet plasma membrane (PPM) fluidity in healthy volunteers, before, during and after a fish-oil supplement. Other variables which might influence membrane fluidity or which might be altered by fish-oil feeding were also studied.
M A T E R I A L S A N D M E T H O D S

Subjects
Eight healthy male volunteers (aged 22-39 years) participated in the study which was approved by the Ethics Committee of the Hampshire Area Health Authority. Each volunteer supplemented his diet with 15 g fish oil (MaxEPA; Seven Seas, Hull)/d in 1-g gelatin capsules. This provided 2.25 g EPA and 1.35 g DHA, plus 69 mg cholesterol/d. Weighed food intake surveys (3 or 7 d) were carried out before and during the period of 6 weeks of fish-oil supplementation. It was a requirement of the Ethics Committee that 3 months should elapse between each fasting blood sample of 200 ml, the minimum volume needed for isolating sufficient platelet plasma membrane for fluidity studies. Thus, blood samples were taken 6 weeks before the period of supplementation, at the end of this period and 3 months after its cessation. All subjects abstained from medication for at least 7 d before donating blood.
Biochemical methods
PPM was prepared by the glycerol lysis techniques (Barber et al. 1971) and characterized by the activities of key marker enzymes: adenylate cyclase (Houslay et al. 1976 ), 5'-nucleotidase (EC 3 . 1 . 3 .5) (Arnich & Wallach, 1971) , ubiquinol-cytochrome-c reductase (EC 1 . 1 0 . 2 . 2 ) (Tisdale, 1976) , phosphodiesterase 1 (EC 3 . 1 . 4 . 1) (Taylor et al. 1977) . Lactate dehydrogenase (EC 1 . 1 . 1 .27) was assayed by incubation with lactic acid followed by spectrophotometric analysis of NADH production at 340 nm. Lactate dehydrogenase activity indicated almost 75 % lysis of platelets. Adenylate cyclase, 5'-nucleotidase and phosphodiesterase were present in the PPM in quantities of 4.9, 12.2 and 3.8 (respectively) times higher than in the platelet homogenate. The higher concentration of these membrane-bound enzymes in the PPM contrasting with the lower level of the cytoplasmic enzyme (039 times) ubiquinol-cytochrome-c oxidoreductase, indicated adequate purity of the isolated PPM.
Fluorescence polarization was measured using the fluorescent probe as previously described (Shinitzky & Barenholz, 1978) . Platelet aggregation in response to ADP and collagen was determined using a Payton Dual Channel aggregometer at 37" and 900 rev/ min. Saline (9 g sodium chloride/l ; 200 pl) was added to 200 yl platelet-poor plasma or 200 yl platelet-rich plasma for 100 % and zero light transmissions respectively. PPM levels of cholesterol and phospholipid were detemined by the methods of Gamble et al. (1978) and Raheja et al. (1973) respectively. Platelet and plasma lipids were extracted in chloroform-methanol (2 : 1 v/v). Phospholipids were isolated by thin-layer chromatography in a solvent system of light petroleum (b.p. 4&60)-diethyl ether-formic acid (80: 20: 2, by vol., with 10 mg butylated hydroxytoluene). Individual phospholipids were separated using two-dimensional thin-layer chromatography : chloroform-methanol-alkali (0.88 ammoniabwater (90: 54: 8-8 : 2.2, by vol.) followed by chloroform-acetonemethanol-acetic acid-water (48 : 63 : 16: 16 : 8, by vol.). The stationary phase was Kieselgel 60 H plus 30 g magnesium carbonate/kg. The fatty acid composition of lipid fractions was PUFA, polyunsaturated fatty acids; PPM, platelet plasma membl'ane; TxB,, thromboxane B,.
Mean value was significantly different from the pre-supplementary value: *P analysed by gas-liquid capillary-column chromatography following transmethylation in sodium methoxide. The conditions of this chromatographic separation were as follows :
wall coated, open tubular fused silica column, 50 m x 0.22 m (internal diameter) and film thickness 0.1 8 pm, liquid phase CP 5.188, column temperature 170", injection temperature 260", detector temperature 250°, oven programme temperature increase from 170 to 180" over 3 min, 3 min at 3"/min, 1 min at 180" followed by 6"/min to 210" for 10 min; carrier gas hydrogen, delivery of 400 mm linear velocity/s. Platelet thromboxane B, was determined by radioimmunoassay (New England Nuclear) following aggregation of platelet-rich plasma in saline (1 : 1, v/v) with 5 pg collagen.
Dietary analysis
Dietary information was analysed using conventional tables of food composition (Paul & Southgate, 1978) .
Statistical methods
Statistical analysis was carried out using the analysis of variance. Mean values were compared using Duncan's multiple range test.
RESULTS
There was a high degree of supplement compliance with no side effects or weight changes noted. The only dietary variable to change during the period of supplementation was the intake of n-3 PUFA which rose by 250 YO (P < 0.05). No significant effects on plasma lipids or on platelet levels of cholesterol or phospholipid were observed. There was no significant change in fluorescence polarization values of isolated PPM during the supplementary period. However, at the final blood sample, the fluorescence polarization value had increased significantly (P < 0.05) over that obtained with the initial blood sample. Platelet aggregation in response to collagen or to low levels of ADP was not altered during the period of fish-oil supplementation. At 5 and 10 p~-A D P (final concentration) there was a significant increase in platelet aggregation during the period of fish-oil supplementation (P < 0.05) which persisted at the 10 p~ level into the post-supplementary period. There were no significant changes in platelet thromboxane B, production. These results are given in Table 1 . The fatty acid compositions of platelet individual phospholipids are given in Table 2 . The period of fish-oil supplementation did not produce any significant changes in the fatty acid compositions of platelet phosphatidyl serine, phosphatidyl inositol or sphingomyelin. In phosphatidyl choline, the levels of oleic acid (18: ln-9) and EPA (20: 5n-3 ) increased significantly during the period of fish-oil supplementation while that of arachidonic acid (20:4n-6) fell significantly during that period (P < 0.05). Palmitic acid (1 6 : 0) was increased significantly both during and after the period of supplementation ( P < 0.05). There were significant increases (P < 0.05) during the period of supplementation in the phosphatidyl ethanolamine levels of oleic acid, EPA , DPA (22:5n-3) and DHA  (22 : 6n-3) . The levels of stearic acid (1 8 : 0) and arachidonic acid fell significantly during this period (P < 0 0 5 ) .
DISCUSSION
As would be expected, the period of fish-oil supplementation led to a substantial increase in the daily intake of n-3 PUFA although the total intake of n-3 and n-6 PUFA remained a relatively constant proportion of energy intake over the three study periods. The dietary intakes are in general agreement with previously recorded information (Sanders & Roshani, 1983; Church et al. 1984; Reeves et al. 1984) . The low levels of serum cholesterol recorded in this study may reflect the nature of the subjects' diets which were characterized by a high ratio of PUFA : saturated fatty acids for each of the three periods (062 (SE 0.06), 0.60 (SE 0.05) and 0.55 (SE 0.1 1) respectively). (This contrasts with the UK average of 0.23.) The diets were also characterized by high intakes of fibre and low intakes of cholesterol.
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The reported effects of n-3 PUFA supplements on blood lipids have been variable (Herold & Kinsella, 1986) . Some studies agree with the findings of the present study that fish-oil supplements do not influence blood lipids in man (Seiss et al. 1980; Terano et al. 1983) . Others have reported a hypolipidaemic effect of fish-oil supplements in hyperlipidaemic patients Phillipson et al. 1985) and in normolipidaemic individuals (Goodnight et al. 1981 ; Sanders & Roshani, 1983; Seynor et al. 1984; Harris et al. 1984; Illingworth et al. 1984) . In general, the reported hypotriglyceridaemic effects of fish-oil supplements are more consistent than the reported hypocholesterolaemic effect (Sanders, 1985) . These widely different results may reflect variation in the degree of exposure, source of n-3 PUFA and initial blood lipid values as well as dietary changes other than n-3 PUFA intake.
In the present study, the period of fish-oil supplementation led to an increase in the platelet total phospholipid level of EPA (0.5-3.8 % w/w) and to a decrease in the level of arachidonic acid (31.5-23.1 % w/w). These changes are in agreement with the many studies of the effect of n-3 PUFA supplements on platelet total phospholipid fatty acids in man (Sanders, 1985) . In the present study, the effects were confined to phosphyatidyl choline and phosphatidyl ethanolamine which agrees with the findings of previous studies (Brox et al. 1981 ; Fisher & Weber, 1983; Ahmed & Holub, 1984; Galloway et al. 1985) .
The effects of n-3 PUFA supplements on platelet aggregation in man have been extensively reported and reveal widely different results : increased ADP-induced platelet aggregation (Sanders et al. 1981) which agrees with the findings of the present study, no effect of ADP on platelet aggregation ; increased ADP-induced platelet aggregation (Seiss et al. 1980; Terano et al. 1983 ). In the present study, collagen-induced platelet aggregation and thromboxane B, release was not influenced by dietary supplements of fish oil in spite of extensive incorporation of EPA into platelet phospholipids. Sanders & Hochland (1983) found that platelet aggregation in response to collagen in healthy volunteers receiving fish-oil supplements was significantly reduced at low levels of stimulation (0.5 yg collagen) but not at high levels (1.0 and 10.0 yg). In contrast, thromboxane B, production was significantly reduced only at the higher levels of stimulation (10 yg). However, the intake of EPA in these studies was 3-6 g/d contrasting with the intake of 2.25 g/d in the present study. Galloway et al. (1985) also found that lower intakes of EPA (1.8 g/d) did not alter collagen-induced platelet thromboxane A, release. While the present study failed to record an effect of n-3 PUFA supplements on either collagen-induced aggregation or thromboxane A, release, a highly significant (P < 0.00 1) correlation (r + 0.63, n 22) was observed between the production of platelet thromboxane A, (measured as thromboxane B,) and platelet phospholipid arachidonic acid levels. Clearly, while the reduction in the mean levels of arachidonic acid, noted during the period of fish-oil supplementation, was not sufficiently consistent to suppress platelet thromboxane B, release, this correlation indicates the capacity of n-3 supplements to inhibit thromboxane A, synthesis when the supplementation is successful in displacing platelet arachidonic acid.
Membrane fluidity can be influenced by a variety of factors, both physical and chemical. Of the physical effectors, temperature, pressure, pH and calcium ions are the most important, their effect being virtually instantaneous. Of the chemical effectors, the niost important are : protein :lipid, sphingomyelin : phosphatidyl choline, acyl-chain length and degree of unsaturation, cholesterol :phospholipid and the sum of the molar proportions of linoleic and oleic acids (Stubbs, 1983; Berlin et al. 1987 ). In the present study, the only variable of PPM lipid composition which altered during the period of fish-oil supplementation was the composition of phospholipid acyl chains. No significant effects of dietary supplementation on phospholipid : cholesterol, sphingomyelin : phosphatidyl choline or protein : lipid in platelet-rich plasma were noted. Furthermore, the distribution of platelet individual phospholipids was not altered by dietary supplementation. It would therefore appear that modification of the fatty acid composition of human platelet phospholipids alone will not influence PPM fluidity. Berlin et al. (1987) , working with rabbit PPM, found no effect of dietary fat source (maize oil, cocoa butter and milk-fat) on membrane fluidity although these authors did find that the addition of 2 g cholesterol/kg to the cocoa-butter diet did significantly lower membrane fluidity. In contrast, Rand et al. (1986) showed a significant increase in platelet membrane fluidity in whole platelets of rats fed on high-fat diets (50 YO energy) compared with low-fat diets ( 5 YO energy). However, these authors did not find a significant difference between oils rich in n-3 PUFA (marine oil) and n-6 PUFA (sunflower oil).
Some of these differences may relate to the tendency of DPH to report localized changes in membrane fluidity given that lipid domains of varying composition are likely to occur (Kannagi et al. 1981) .
Thus, it is unlikely that the effects of n-3 PUFA on platelet function, reported both for animals and man, is related to changes in membrane fluidity. This work was funded by the Medical Reseach Council.
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